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Key Clinical Message
Deep brain stimulation in an awake patient presents several unique challenges
to the anesthesiologist. It is important to understand the various stages of the
procedure and the complexities of anesthetic management in order to have a
successful surgical outcome and provide a safe environment for the patient.
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Introduction
Deep brain stimulation (DBS) is a neurosurgical tech-
nique aimed at improving “functional” neurologic disor-
ders. To facilitate intraoperative neurophysiologic
microelectrode recording (MER) and neurocognitive test-
ing of the eloquent parts of the brain, DBS is commonly
performed via an “awake” approach under a local anes-
thetic and conscious sedation. While a deeper plane of
anesthesia can be used during the portion of the proce-
dure not involved in testing, an awake and cooperative
patient with fully preserved brain function is essen-
tial during MER to ensure accurate lead placement
[1, 2].
Case Description
Our case involved a developmentally delayed 24-year old,
80-kg male with traumatic brain injury (TBI) as an infant
with resultant post-traumatic stroke, hydrocephalus, and
right upper extremity hemidystonia, causing a prominent
dystonic flexor position at the elbow. The surgical plan
included implantation of intracranial DBS leads in the
globus pallidus internus in an attempt to relieve the
hemidystonia. A peripheral IV was placed and midazolam
2 mg was administered en route to the OR. Standard
ASA monitors were applied along with 2 L/min of oxygen
via nasal cannula, while the neurosurgical team prepared
for head frame placement. A dexmedetomidine intrave-
nous infusion at 0.5 lg/kg/h was started, and a total of
1.2 lg/kg of fentanyl was administered incrementally for
local anesthetic infiltration at the head frame pin sites.
During this period, the patient maintained spontaneous
ventilation and did not react to local infiltration, pin
insertion, or head frame manipulation.
A radial arterial line and second peripheral IV were
placed under local and propofol infusion at 100 lg/kg/
min. Before MER and neurocognitive testing, propofol
was turned off in order to transition to the “awake” seg-
ment of the procedure. The patient was able to follow
commands under the dexmedetomidine infusion alone.
Exceptional quality MER recordings were obtained. Once
ª 2015 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use,
distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
1
MER was complete, the propofol infusion was restarted
to supplement the dexmedetomidine infusion during sur-
gical site closure. The patient’s postoperative course was
uneventful, and he was discharged home 2 days after the
procedure. At patient’s 6-month follow up clinic visit, he
had a dramatic reduction in his right upper extremity tre-
mor and had a significant improvement in his ability to
perform daily activities.
Discussion
DBS involves the placement of wire electrodes into deep
brain nuclei. For movement disorders, these deeper brain
structures include the subthalamic nucleus, internal seg-
ment of the globus pallidus, and thalamic nucleus ventral-
is intermedius. Electrical impulses are delivered to these
structures with the objective of altering specific neural
networks, resulting in a therapeutic effect. The electrodes
are then connected to an implanted pacemaker that pro-
duces high-frequency stimulations that help ameliorate
the clinical manifestations of functional neurologic disor-
ders, while having the added qualities of titratability and
reversibility [3].
Targeting specific deep brain structures in DBS surgery
is based on stereotactic principles that use advanced brain
imaging and atlases. The surgical trajectory is guided by
stereotactic platforms, which may be framed or frameless.
The deep brain nuclei targets are verified by their electro-
physiological signature using intraoperative neurophysio-
logic mapping. This presents several unique challenges to
the anesthesiologist: providing patient reassurance and
comfort, especially during head frame placement and Burr
hole drilling, and maintaining this level of supportive care
over a potentially long surgery; ensuring proper position-
ing to allow for safe and optimal surgical conditions; and
maintaining access to the patient’s airway while anticipat-
ing emergency airway interventions in the event ventila-
tory compromise occurs under sedation. This is especially
important as the head frame system (Fig. 1) can impair
access to the airway, making mask ventilation problem-
atic. Patient cooperation, providing an anesthetic tech-
nique that will minimally interfere with MER, and
maintaining spontaneous ventilation and airway patency
are crucial to a successful outcome in these cases. Finally,
an appropriate blood pressure should be maintained in
order to minimize the risk of intracranial bleeding, a
well-known complication in DBS procedures [4]. All of
these challenges are magnified in the younger or develop-
mentally delayed patient population.
The anesthetic management of an awake craniotomy
has changed over the past 20 years in an attempt to
address the aforementioned challenges. Currently, the
most popular technique is the “asleep-awake-asleep” tech-
nique. This employs a heavier sedation or general anes-
thesia during the initial stages, alternating with
consciousness using rapid-onset medications with a short
duration of action during brain mapping and neurocogni-
tive testing [2]. After mapping is complete, deep sedation
or general anesthesia can be reestablished for surgical clo-
sure and removal of the pins. Propofol, remifentanil, and
dexmedetomidine are some of the anesthetics that have
been used for awake craniotomy (Table 1). While propo-
fol and remifentanil are short-acting, propofol can attenu-
ate MER and remifentanil may cause muscle rigidity.
Both drugs can result in respiratory depression, so they
must be titrated carefully. While high doses of dexmede-
tomidine can abolish MER, low dose infusion rates (0.3–
0.6 lg/kg/h) usually preserve MER integrity, while also
providing analgesia and sedation without respiratory
depression [1]. The a-2A receptors in the locus ceruleus
are responsible for the sedative, analgesic, and sympatho-
lytic effects of dexmedetomidine. This specific effect over
a-2A receptors may allow cortical neurons to continue
functioning upon stimulation in contrast to propofol or
even barbiturates that produce generalized neuronal
hyperpolarization.
In a recent case study, 6 pediatric patients with severe
dystonia successfully underwent DBS procedures with the
use of low-dose dexmedetomidine as part of the anes-
thetic technique with unimpaired neuroelectrophysiologi-
cal signals [5]. Since it does not directly affect the activity
of subthalamic neurons, dexmedetomidine may be an
ideal sedative medication for neurophysiologic monitor-
ing [6]. Low-dose dexmedetomidine (0.1–0.4 lg/kg/h)
infusion has been shown to produce MER from subtha-
Figure 1. Head frame for stereotactic neurosurgery (courtesy of
Elekta).
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lamic neurons similar to MER during the awake state [7].
Additionally, dexmedetomidine use has decreased the in-
traoperative need for antihypertensive medications used
to prevent intracranial hemorrhage [4].
As seen in the presented case, the surgeon was able to
perform successful cortical mapping during low-dose dex-
medetomidine infusion allowing the patient to follow
simple verbal commands. There was no evidence of respi-
ratory depression, and dexmedetomidine also likely
decreased the amount of narcotic needed for this stimu-
lating procedure. It has been well-documented in the lit-
erature that dexmedetomidine decreases the need for
narcotic administration in various surgical procedures.
Despite the patient’s severe dystonia and developmental
delay, he remained a good candidate for DBS via an
awake approach. Dexmedetomidine helped facilitate this
by decreasing the patient’s anxiety and restlessness during
the procedure and allowing for an easy transition from
sedation to responsiveness.
While DBS is most commonly performed for generalized
dystonias, there are few reports in the literature describing
DBS for TBI-induced dystonias. Here, we have presented a
case of DBS in an awake patient with post-traumatic hemi-
dystonia. Although various anesthetic techniques and com-
binations of drugs have been described for an awake
craniotomy, dexmedetomidine appears to be useful in pro-
cedures, involving DBS and neurophysiologic monitoring.
As the indications for DBS in the pediatric patient popula-
tion are expanding and the demand for this procedure
increases, the creation and implementation of standardized
protocols guiding the complex anesthetic management for
these cases would be of value.
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Table 1. Commonly used anesthetic agents in awake craniotomies and DBS.
Anesthetic agent Advantages Disadvantages Effects on MER for DBS
Benzodiazepines Sedation
Anxiolysis
Amnestic
May induce dyskinesia
Potentiate ventilatory depressant
effects of narcotics
Depresses swallowing reflex
Decreases upper airway activity
Abolishes MER
Dexmedetomidine Cooperative” sedation
Easily arousable
Analgesia
Minimal respiratory depressant effects
Hemodynamic stability
Bradycardia
Hypotension
Low-dose infusion rates: minimal effects on MER
High-dose infusion rates: suppress MER signals
Ketamine Analgesia
Minimal respiratory depressant effects
Hypersalivation
Emesis
Transient myoclonus
Hyperreflexia
May increase ICP
Emergence delirium
Hypertension
Minimal effects on MER
Narcotics Sedation
Analgesia
Cough suppression
Remifentanil is short acting
Respiratory depression
Rigidity
Airway obstruction
Nausea/vomiting
Potentially increases ICP
Pruritus
Suppression of tremors
Minimal effects on MER
Propofol Sedation
Short duration of action
Antiemetic properties
Widely used
Predictable emergence profile
Respiratory depression
Pain on injection
Tendency to cause sneezing
Abolishes tremors
Induces dyskinesia
Attenuation of MER
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